The 2026 Healthtech Messaging Index
AcuityMD
acuitymd.com·scored September 1, 2026
28/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push AcuityMD into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for MedTech sales intelligence and commercial operations platform, it named:
Buyer we put in the prompt: VP of Sales, Sales Leader, or Commercial Operations leader at a medical device or MedTech company. Both the buyer and the category were inferred from AcuityMD’s homepage alone. The model had no web access.
AcuityMD was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "MedTech sales intelligence and commercial operations platform", and described you accurately: "AcuityMD is a sales intelligence platform built specifically for MedTech companies, helping commercial teams identify target physicians and facilities, prioritize opportunities, and optimize territory coverage using medical claims data and AI.". Your positioning is landing with the machines.
Overall assessment
AcuityMD's biggest strength is its proof density ... concrete metrics (97% forecast accuracy, 10x faster onboarding, $300K+ pipeline uncovered) paired with named customer logos create genuine trust signals that most B2B homepages lack. The biggest gap is a complete absence of competitive acknowledgment and a rebellion narrative: the page never names what buyers are doing today, who they'd otherwise choose, or what broken status quo AcuityMD is replacing, which leaves the positioning feeling confident but not insurgent.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, alternatives, or 'do nothing' tradeoffs anywhere on the page.”
The page never acknowledges what buyers use today, who competitors are, or the cost of doing nothing beyond a vague reference to frustration ... alternatives are completely ignored.
All 19 signals, scored 0 to 2.
Total 28/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“Built for MedTech. Trusted by 500+ medical device companies." / "The MedTech intelligence platform.”
Within seconds, a visitor knows this is for MedTech/medical device companies, it's an intelligence platform, and it's broadly trusted ... industry, product type, and credibility all visible above the fold.
- 1
02Rebellion / Movement
“you don't have accurate, usable data, which leaves you feeling frustrated, and your sales goals at risk”
There's a named pain (bad data, frustrated reps) but no named enemy, no competitor called out, and no explicit industry status quo being rebelled against ... the page is problem-aware but not insurgent.
- 1
03Owned Language & Category
“The MedTech intelligence platform" and "AcuityAI”
AcuityMD hints at owning 'MedTech intelligence platform' and coins 'AcuityAI,' but neither term is defined or framed distinctively enough for an AI to cite it as an owned category.
- 2
04ICP Clarity
“For sales leaders" / "For sales reps" / "For commercial operations" / "For marketers" / "For national accounts”
The page explicitly segments five distinct buyer roles within MedTech commercial teams, making it immediately clear whether you're the intended audience.
- 1
05Problem Leadership
“you don't have accurate, usable data, which leaves you feeling frustrated, and your sales goals at risk”
The problem is named but buried mid-page after the hero leads with the solution ('The MedTech intelligence platform') ... the page does not open with the buyer's problem.
- 2
06Solution Clarity
“Move faster on your best opportunities with every team aligned ... now powered by AcuityAI.”
Combined with 'The MedTech intelligence platform,' a visitor can repeat in one sentence what AcuityMD does: it's a MedTech intelligence platform that helps commercial teams move faster on their best opportunities.
- 1
07Cost of Inaction
“your sales goals at risk" and "leaves you feeling frustrated”
The cost of inaction is gestured at (frustrated reps, goals at risk) but never quantified or made viscerally specific ... no dollar figures lost, deals missed, or market share ceded by staying the course.
- 1
08Promised Land
“Smarter outreach, faster sales, and more life-changing technology to patients who need it.”
There's a promised land but it's generic ('smarter,' 'faster') ... no concrete after-state like 'own your territory in 90 days' or a specific revenue outcome the buyer will personally live in.
Trust Signal
4 signals
- 2
09Proof & Evidence
“97% forecast accuracy" / "10x faster onboarding" / "$300K+ pipeline uncovered" / "3x faster sales process”
Multiple concrete before/after deltas with real numbers attached to named companies appear across the testimonial section ... this is strong, specific proof.
- 2
10Social Proof
“Olympus" / "Teleflex" / "BD" / "Merit Medical" + named case study quotes from Aerin Medical, AnX Robotica, Kuros, Route 92, Corza, Intellijoint”
Named logos, named companies in testimonials, and linked case studies provide layered social proof ... the only gap is that individual names/titles are absent from the quotes.
- 1
11Authority & Credibility
“AcuityMD was built by former MedTech professionals”
Founder/builder credentials are asserted in one line but no names, frameworks, research authorship, or external recognition are cited to demonstrate authority rather than claim it.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, alternatives, or 'do nothing' tradeoffs anywhere on the page.”
The page never acknowledges what buyers use today, who competitors are, or the cost of doing nothing beyond a vague reference to frustration ... alternatives are completely ignored.
AI Signal
6 signals
- 2
13Customer Focus
“Commercial teams across MedTech...use AcuityMD to accelerate product adoption, grow revenue, and scale more efficiently.”
The testimonials and outcomes section consistently centers the customer's transformation (their revenue, their reps, their onboarding) rather than AcuityMD's own feature roadmap.
- 1
14AI-Parmesan Index
“now powered by AcuityAI" / "AI-powered insights to help close them" / "AI users are 3x more likely to hit quota”
AI is mentioned in the headline banner and hero but mechanistic explanation of how AcuityAI works is absent ... it reads as AI-sprinkled, not AI-substantiated, though the 3x stat adds partial credibility.
- 2
15LLM Quotability
“The team most active in AcuityMD is Kuros's highest-selling team." / "97% forecast accuracy" / "10x faster onboarding”
Several short, declarative, stat-backed sentences exist that an LLM could lift verbatim as citations when recommending this platform.
- 1
16Copyright Freshness
“No visible dates on testimonials or blog posts in the scraped content; copyright year not visible in the provided markdown.”
The new research banner implies recency ('2026') but no case study dates, blog post dates, or copyright year are visible in the page content provided, leaving recency signals weak.
- 2
17Entity Distinctiveness
“purpose-built for the MedTech industry's unique commercialization process" / "500+ medical device companies" / "AcuityAI”
The MedTech-only vertical focus, the 500+ customer claim, and the named sub-brand AcuityAI give this company a distinct enough fingerprint that an AI could not confuse it with a generic CRM or generic sales intelligence tool.
- 2
18AI Recommendation Check
“AI described you as: "AcuityMD is a sales intelligence platform built specifically for MedTech companies, helping commercial teams identify target physicians and facilities, prioritize opportunities, and optimize territory coverage using medical claims data and AI.”
AI named you when asked who it recommends for "MedTech sales intelligence and commercial operations platform", and described you accurately: "AcuityMD is a sales intelligence platform built specifically for MedTech companies, helping commercial teams identify target physicians and facilities, prioritize opportunities, and optimize territory coverage using medical claims data and AI.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 2
19Path & CTA Clarity
“1. Build your strategy... 2. Uncover insights... 3. Win more business" + "Request a demo" primary CTA”
An explicit three-step numbered process is present, paired with a clear primary CTA ('Request a demo') and a softer secondary path (About us link), all working together on the page.
Keep the lead
AI already names AcuityMD. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing AcuityMD the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.